Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Avanti Polar Lipids LLC has 1 pending office action in the Chemistry & Materials technology area. Prosecution is currently limited to 1 distinct examiner and 1 distinct art unit. This indicates a very specific focus for the company's active patent applications, likely centered on a single lipid or chemical innovation. The use of 1 distinct examiner suggests that the company's current workload is manageable through a single point of contact at the patent office. This concentration allows for a consistent prosecution strategy within the chemistry sector.
XU, XIAOYUN is the busiest examiner, overseeing 1 busiest examiner pending action. This single action constitutes the entire pending workload for the company. The examiner's review within this 1 art unit is the sole factor currently influencing the company's patent prosecution outcomes. Practitioners should prioritize understanding the specific examination style of this 1 examiner to effectively resolve the 1 pending action. The company's immediate patent success in the Chemistry & Materials sector depends entirely on this single interaction. The resolution of this case will define the company's current standing in the chemical field.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| XU, XIAOYUN | 1 | 59.9% | +31.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17616327 | UNIVERSAL LIPID QUANTITATIVE STANDARDS FOR USE IN LIPIDOMICS | XU, XIAOYUN | — |
| Art Unit | Apps |
|---|---|
| 1797 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17616327 | UNIVERSAL LIPID QUANTITATIVE STANDARDS FOR USE IN LIPIDOMICS | XU, XIAOYUN | 1797 | §103 | Final Rejection | — | Pending | Dec 03, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAvanti Polar Lipids LLC has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Xiaoyun Xu has the most, with 1 of Avanti Polar Lipids LLC's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
